News Focus
News Focus
icon url

codaras

06/26/18 4:59 PM

#38 RE: hedgeclipper #37

Agreed!
icon url

MinnieM

06/26/18 5:05 PM

#39 RE: hedgeclipper #37

It's too early to know this since no clinical trials have been started yet. I've learned the hard way that entering biotech too early is usually a mistake.

https://clinicaltrials.gov/ct2/results?cond=&term=CohBar+Inc&cntry=&state=&city=&dist=&Search=Search

Please correct me if I'm wrong and they've at least done a phase I safety trial in another country. I've not had time to do the research and it appears you may have done so.

Thanks...






In Reply to 'hedgeclipper'
IMO a buying opportunity. All the fundamentals still there for CohBar to be the next (and best) NASH play.